Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Gastrointestinal 3Thoracic 2Other hematologic neoplasm 2Lymphoid 2Genitourinary 2Tumor-Agnostic 1Other 1Myeloid 1Head & Neck 1Endocrine 1

Conditions

Breast Neoplasms 3Pain 1Inflammation 1Breast Diseases 1Agnosia 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Ibuprofen × Breast × Clear all
NCT02463383 2017-12-12

EPPNASE

University of Copenhagen

Phase EARLY_PHASE1 Completed
25 enrolled
Breast

Breast Neoplasms

NCT02461056 2015-06-03

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

Samsung Medical Center

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

NCT02141139 2014-05-19

Perioperative Inflammation and Breast Cancer Outcome

Samsung Medical Center

Phase 3 Unknown
1,568 enrolled
Breast

Breast Neoplasms, Inflammation

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed
150 enrolled
Breast

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡